droxidopa
Drug ingredientThis chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
Where It Comes From
23 FDA-registered drug labelers
Apicore Pharmaceuticals Private Limited
Ascend Laboratories, LLC
Aurobindo Pharma Limited
Bionpharma Inc.
Camber Pharmaceuticals, Inc.
CivicaScript LLC
Clarochem Ireland Ltd
Dasami Lab Private Limited
Golden State Medical Supply, Inc.
Lundbeck Pharmaceuticals LLC
Lupin Pharmaceuticals, Inc.
MAJOR PHARMACEUTICALS
MSN Life Sciences Private Limited
Novadoz Pharmaceuticals LLC
Nuray Chemicals Private Limited
Piramal Pharma Limited
Quimica Sintetica S.A.
ScieGen Pharmaceuticals Inc
Slate Run Pharmaceuticals, LLC
Sumitomo Pharma Co., Ltd.
Sun Pharmaceutical Industries, Inc.
Zydus Lifesciences Limited
Zydus Pharmaceuticals USA Inc.
Why It Matters
Sectors
Health
Downstream Uses
Appears in 2 drug and cosmetic product listings (FDA).
- •Droxidopa
- •Northera
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No FDA shortage records
Chemical Identity
CAS23651-95-8
PubChem CID92974
DTXSIDDTXSID6046422
FormulaC9H11NO5
Mol. Weight213.19 g/mol
SMILESC1=CC(=C(C=C1C(C(C(=O)O)N)O)O)O
Data Sources
929742026-04-07
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/droxidopa/cids/JSON
Archive: data/sources/pubchem_name/droxidopa.json
CAS 23651-95-82026-04-25
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json
bulk match2026-04-07
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json